TickerFacts.

Dexcom Inc (DXCM): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.75B
As of 2025-12-31
$2.62B
As of 2026-06-30
+8.8%
3-year compound annual growth
+12.1%
5-year compound annual growth
2009-12-31: -$18.45M2010-12-31: $61.00M2011-12-31: $104.50M2012-12-31: $77.00M2013-12-31: $84.10M2014-12-31: $140.20M2015-12-31: $221.20M2016-12-31: $283.80M2017-12-31: $419.40M2018-12-31: $663.30M2019-12-31: $882.60M2020-12-31: $1.55B2021-12-31: $2.04B2022-12-31: $2.13B2023-12-31: $2.07B2024-12-31: $2.10B2025-12-31: $2.75B$2.75B
2009-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$2.75B+30.6%2026-02-12, Balance as of period end
2024-12-31$2.10B+1.6%2026-02-12, Balance as of period end
2023-12-31$2.07B-3.0%2026-02-12, Balance as of period end
2022-12-31$2.13B+4.4%2025-02-18, Balance as of period end
2021-12-31$2.04B+31.6%2024-02-08, Balance as of period end
2020-12-31$1.55Bn/c2023-02-09, Balance as of period end
2019-12-31$882.60M+33.1%2022-02-14, Balance as of period end
2018-12-31$663.30M+58.2%2021-02-11, Balance as of period end
2017-12-31$419.40M+47.8%2020-02-13, Balance as of period end
2016-12-31$283.80M+28.3%2019-02-21, Balance as of period end
2015-12-31$221.20M+57.8%2018-02-27, Balance as of period end
2014-12-31$140.20M+66.7%2017-02-28, Balance as of period end
2013-12-31$84.10M+9.2%2016-02-23, Balance as of period end
2012-12-31$77.00M-26.3%2015-02-25, Balance as of period end
2011-12-31$104.50M+71.3%2014-02-20, Balance as of period end
2010-12-31$61.00Mn/m2013-02-21, Balance as of period end
2009-12-31-$18.45Mn/a2012-02-23, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Dexcom Inc (DXCM)2025-12-31$2.75B+30.6%
ResMed Inc (RMD)2026-06-30$6.59B+10.3%
MiniMed Group, Inc. (MMED)2026-04-24$3.61B+8.4%
West Pharmaceutical Services Inc (WST)2025-12-31$3.18B+18.4%
Globus Medical Inc (GMED)2025-12-31$4.57B+9.5%
Insulet Corp (PODD)2025-12-31$1.52B+25.1%
Solventum Corp (SOLV)2025-12-31$5.05B+70.6%
ICU Medical Inc (ICUI)2025-12-31$2.12B+8.1%
Teleflex Inc (TFX)2025-12-31$3.12B-27.0%

Compare DXCM, RMD, MMED, WST side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗